Holocene Advisors’s Globus Medical GMED Stock Holding History

Holocene Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.6M	Sell	399,932 -373,902	-48%	-$31.8M	0.07%	238
2026 Q1	$66.7M	Buy	+773,834	New	+$69.5M	0.16%	154
2025 Q2	–	Sell	-460,087	Closed	-$33.7M	–	804
2025 Q1	$33.7M	Buy	+460,087	New	+$38M	0.1%	195
2024 Q1	–	Sell	-137,193	Closed	-$7.31M	–	772
2023 Q4	$7.31M	Buy	137,193 +53,637	+64%	+$2.61M	0.03%	305
2023 Q3	$4.15M	Sell	83,556 -47,901	-36%	-$2.68M	0.02%	423
2023 Q2	$7.83M	Buy	131,457 +115,590	+728%	+$6.59M	0.03%	299
2023 Q1	$899K	Buy	+15,867	New	+$1.02M	﹤0.01%	598
2021 Q2	–	Sell	-10,691	Closed	-$659K	–	874
2021 Q1	$659K	Buy	10,691 +2,945	+38%	+$187K	﹤0.01%	730
2020 Q4	$505K	Buy	+7,746	New	+$445K	﹤0.01%	639
2020 Q1	–	Sell	-32,659	Closed	-$1.92M	–	727
2019 Q4	$1.92M	Buy	32,659 +15,006	+85%	+$815K	0.02%	411
2019 Q3	$902K	Buy	+17,653	New	+$841K	0.01%	510
2019 Q2	–	Sell	-5,433	Closed	-$268K	–	682
2019 Q1	$268K	Buy	+5,433	New	+$246K	﹤0.01%	567
2018 Q4	–	Sell	-7,659	Closed	-$435K	–	714
2018 Q3	$435K	Buy	+7,659	New	+$403K	0.01%	577

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Holocene Advisors's GMED Position: Q2 2026 in Review

Holocene Advisors reduced its Globus Medical (GMED) stake by 48% in Q2 2026, selling an estimated $31.8M and leaving 399,932 shares worth $31.6M. The position accounts for 0.07% of the portfolio, ranked #238.

Holocene Advisors first reported a position in GMED in Q3 2018 and has held it in 13 quarters since. The position peaked at $66.7M in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Holocene Advisors held 399,932 shares of Globus Medical worth $31.6M as of Q2 2026.
Holocene Advisors sold 373,902 Globus Medical shares in Q2 2026, an estimated $31.8M.
Globus Medical made up 0.07% of Holocene Advisors's portfolio in Q2 2026, its #238 holding.
Holocene Advisors first reported a position in Globus Medical in Q3 2018 and has held it in 13 quarters since.
Holocene Advisors's Globus Medical position peaked at $66.7M in Q1 2026.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.